SUN-386 Treatment Outcomes of Intravenous Zoledronic Acid vs Oral Alendronate in Postmenopausal Women with Osteoporosis

In real practice, many patients with osteoporosis are poorly compliant with oral bisphosphonate, partly due to gastrointestinal side effects and partly due to medication procedure leading to premature termination of treatment. Once yearly intravenous zoledronic acid is well tolerated; little or no g...

Descripción completa

Detalles Bibliográficos
Autores principales: Pyone, Zar Chi, Aung, Moe Wint, Myint, Thein, Khin, Than Saw, Hlaing, Thinn Thinn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Bone and Mineral Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208430/
http://dx.doi.org/10.1210/jendso/bvaa046.850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208430/
http://dx.doi.org/10.1210/jendso/bvaa046.850

Ejemplares similares